Insider trades

Barbara Leyman, Chief Officer of Sutro Biopharma STRO, has filed 7 transactions, none an open-market purchase or sale. The latest trade was on 25/07/08.

Barbara Leyman

Chief Business Officer
First filing
24/07/10
Trades
7 trades
Buys / sales
0 / 0
12-month net buying
No record
Last trade
25/07/08

Trading activity

Transactions

No filed transactions.